High-dose-rate brachytherapy plus neck dissection for nodal disease

Jonathan J. Beitler, Madhur K. Garg, Randall P. Owen, Catherine Sarta, Richard V. Smith, Ravindra Yaparpalvi

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Background. Regional control for advanced nodal disease has been only marginally affected by concurrent chemoradiation, hyperfractionation, concomitant boost, or accelerated external radiation. Methods. Twenty-five necks in 24 patients received brachy-therapy treatment (20 Gy in 10 twice-daily fractions) in addition to external radiation, neck dissection ± chemotherapy. Indications for brachytherapy included initial treatment of bulky disease (n = 12), recurrence of neck disease in a previously treated patient with at least a 3-month disease-free interval (n = 6), persistent disease after a curative efforts (n = 4), inadequate external radiation (ie, <40 Gy) due to either intolerance or noncompliance (n = 3). Results. Overall actuarial regional control was 67% at 2 years. Regional control for those receiving brachytherapy as part of their initial treatment was 82% despite a mean nodal diameter of 8.7 cm (range, 5-15 cm). The 2-year actuarial regional control was 56% for the patients with a disease-free interval of at least 3 years. Conclusion. High-dose-rate brachytherapy produced excellent regional control.

Original languageEnglish (US)
Pages (from-to)933-938
Number of pages6
JournalHead and Neck
Volume30
Issue number7
DOIs
StatePublished - Jul 2008

Fingerprint

Neck Dissection
Brachytherapy
Radiation
Neck
Therapeutics
Recurrence
Drug Therapy

Keywords

  • Brachytherapy
  • Neck disease
  • Neck dissection-regional control

ASJC Scopus subject areas

  • Otorhinolaryngology

Cite this

High-dose-rate brachytherapy plus neck dissection for nodal disease. / Beitler, Jonathan J.; Garg, Madhur K.; Owen, Randall P.; Sarta, Catherine; Smith, Richard V.; Yaparpalvi, Ravindra.

In: Head and Neck, Vol. 30, No. 7, 07.2008, p. 933-938.

Research output: Contribution to journalArticle

Beitler, Jonathan J. ; Garg, Madhur K. ; Owen, Randall P. ; Sarta, Catherine ; Smith, Richard V. ; Yaparpalvi, Ravindra. / High-dose-rate brachytherapy plus neck dissection for nodal disease. In: Head and Neck. 2008 ; Vol. 30, No. 7. pp. 933-938.
@article{9a684271901a4f858325cf1c2de00c74,
title = "High-dose-rate brachytherapy plus neck dissection for nodal disease",
abstract = "Background. Regional control for advanced nodal disease has been only marginally affected by concurrent chemoradiation, hyperfractionation, concomitant boost, or accelerated external radiation. Methods. Twenty-five necks in 24 patients received brachy-therapy treatment (20 Gy in 10 twice-daily fractions) in addition to external radiation, neck dissection ± chemotherapy. Indications for brachytherapy included initial treatment of bulky disease (n = 12), recurrence of neck disease in a previously treated patient with at least a 3-month disease-free interval (n = 6), persistent disease after a curative efforts (n = 4), inadequate external radiation (ie, <40 Gy) due to either intolerance or noncompliance (n = 3). Results. Overall actuarial regional control was 67{\%} at 2 years. Regional control for those receiving brachytherapy as part of their initial treatment was 82{\%} despite a mean nodal diameter of 8.7 cm (range, 5-15 cm). The 2-year actuarial regional control was 56{\%} for the patients with a disease-free interval of at least 3 years. Conclusion. High-dose-rate brachytherapy produced excellent regional control.",
keywords = "Brachytherapy, Neck disease, Neck dissection-regional control",
author = "Beitler, {Jonathan J.} and Garg, {Madhur K.} and Owen, {Randall P.} and Catherine Sarta and Smith, {Richard V.} and Ravindra Yaparpalvi",
year = "2008",
month = "7",
doi = "10.1002/hed.20799",
language = "English (US)",
volume = "30",
pages = "933--938",
journal = "Head and Neck",
issn = "1043-3074",
publisher = "Wiley-Liss Inc.",
number = "7",

}

TY - JOUR

T1 - High-dose-rate brachytherapy plus neck dissection for nodal disease

AU - Beitler, Jonathan J.

AU - Garg, Madhur K.

AU - Owen, Randall P.

AU - Sarta, Catherine

AU - Smith, Richard V.

AU - Yaparpalvi, Ravindra

PY - 2008/7

Y1 - 2008/7

N2 - Background. Regional control for advanced nodal disease has been only marginally affected by concurrent chemoradiation, hyperfractionation, concomitant boost, or accelerated external radiation. Methods. Twenty-five necks in 24 patients received brachy-therapy treatment (20 Gy in 10 twice-daily fractions) in addition to external radiation, neck dissection ± chemotherapy. Indications for brachytherapy included initial treatment of bulky disease (n = 12), recurrence of neck disease in a previously treated patient with at least a 3-month disease-free interval (n = 6), persistent disease after a curative efforts (n = 4), inadequate external radiation (ie, <40 Gy) due to either intolerance or noncompliance (n = 3). Results. Overall actuarial regional control was 67% at 2 years. Regional control for those receiving brachytherapy as part of their initial treatment was 82% despite a mean nodal diameter of 8.7 cm (range, 5-15 cm). The 2-year actuarial regional control was 56% for the patients with a disease-free interval of at least 3 years. Conclusion. High-dose-rate brachytherapy produced excellent regional control.

AB - Background. Regional control for advanced nodal disease has been only marginally affected by concurrent chemoradiation, hyperfractionation, concomitant boost, or accelerated external radiation. Methods. Twenty-five necks in 24 patients received brachy-therapy treatment (20 Gy in 10 twice-daily fractions) in addition to external radiation, neck dissection ± chemotherapy. Indications for brachytherapy included initial treatment of bulky disease (n = 12), recurrence of neck disease in a previously treated patient with at least a 3-month disease-free interval (n = 6), persistent disease after a curative efforts (n = 4), inadequate external radiation (ie, <40 Gy) due to either intolerance or noncompliance (n = 3). Results. Overall actuarial regional control was 67% at 2 years. Regional control for those receiving brachytherapy as part of their initial treatment was 82% despite a mean nodal diameter of 8.7 cm (range, 5-15 cm). The 2-year actuarial regional control was 56% for the patients with a disease-free interval of at least 3 years. Conclusion. High-dose-rate brachytherapy produced excellent regional control.

KW - Brachytherapy

KW - Neck disease

KW - Neck dissection-regional control

UR - http://www.scopus.com/inward/record.url?scp=47549116825&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=47549116825&partnerID=8YFLogxK

U2 - 10.1002/hed.20799

DO - 10.1002/hed.20799

M3 - Article

VL - 30

SP - 933

EP - 938

JO - Head and Neck

JF - Head and Neck

SN - 1043-3074

IS - 7

ER -